These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10726478)

  • 1. [Immunomodulation after organ grafting by novel immunosuppressive drug and gene transfection].
    Suzuki S; Li XK; Okuyama T; Tamura A; Funeshima N; Enosawa S; Ohba M; Amemiya H
    Nihon Rinsho Meneki Gakkai Kaishi; 1999 Dec; 22(6):422-7. PubMed ID: 10726478
    [No Abstract]   [Full Text] [Related]  

  • 2. New paradigms in immunosuppression.
    Huizinga R; Voyer T
    CANNT J; 2003; 13(3):66-8. PubMed ID: 14596200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunosuppressive agent FTY720].
    Kobayakawa T; Chiba K
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1188-92. PubMed ID: 10771694
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of FTY720 in rat small bowel transplantation: apoptosis of crypt cells and lymphocytes in gut-associated lymphoid tissues.
    Sugito K; Koshinaga T; Inoue M; Ikeda T; Hagiwara N; Kusafuka T; Fukuzawa M
    Transplant Proc; 2006 Nov; 38(9):3058-60. PubMed ID: 17112899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fingolimod. Mitsubishi Pharma/Novartis.
    Dumont FJ
    IDrugs; 2005 Mar; 8(3):236-53. PubMed ID: 15772896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTY720--the first compound of a new promising class of immunosuppressive drugs.
    Kunzendorf U; Ziegler E; Kabelitz D
    Nephrol Dial Transplant; 2004 Jul; 19(7):1677-81. PubMed ID: 15199193
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor counterattack--concept and reality.
    Igney FH; Behrens CK; Krammer PH
    Eur J Immunol; 2000 Mar; 30(3):725-31. PubMed ID: 10741386
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fingolimod - a new immunomodulator].
    Friedrich FW; Eschenhagen T
    Dtsch Med Wochenschr; 2009 Oct; 134(42):2127-31. PubMed ID: 19809964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTY720 immunomodulation: optimism for improved transplant regimens.
    Ferguson R
    Transplant Proc; 2004 Mar; 36(2 Suppl):549S-553S. PubMed ID: 15041404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of cardiac allograft rejection by real-time PCR analysis of circulating mononuclear cells.
    Schoels M; Dengler TJ; Richter R; Meuer SC; Giese T
    Clin Transplant; 2004 Oct; 18(5):513-7. PubMed ID: 15344952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of FTY720 and ex vivo graft irradiation in rat small bowel transplantation: apoptosis of crypt cells and lymphocytes.
    Sugito K; Inoue M; Ikeda T; Hagiwara N; Koshinaga T; Kusafuka T
    Transplant Proc; 2007 Dec; 39(10):3432-5. PubMed ID: 18089399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.
    Eberle J; Fecker LF; Hossini AM; Wieder T; Daniel PT; Orfanos CE; Geilen CC
    Oncogene; 2003 Dec; 22(57):9131-41. PubMed ID: 14668794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Fas, FasL, and soluble Fas mRNA in endomyocardial biopsies of human cardiac allografts.
    Pérez EC; Shulzhenko N; Morgun A; Diniz RV; Almeida DR; Musatti CC; Gerbase-DeLima M
    Hum Immunol; 2006; 67(1-2):22-6. PubMed ID: 16698421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTY720, a new immunosuppressant, as rescue therapy in mouse cardiac transplantation.
    Wang MH; Milekhin V; Zhang H; Huang HZ
    Acta Pharmacol Sin; 2003 Sep; 24(9):847-52. PubMed ID: 12956930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of intestinal allograft rejection by FTY720 and costimulation blockade.
    Yan S; Rodriguez-Barbosa JI; Pabst O; Beckmann JH; Brinkmann V; Förster R; Hoffmann MW
    Transplant Proc; 2005; 37(1):114-5. PubMed ID: 15808565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats.
    Maeda A; Goto M; Zhang J; Bennet W; Groth CG; Korsgren O; Wennberg L
    Transplantation; 2003 Apr; 75(8):1409-14. PubMed ID: 12717240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A strategy for inducing immune tolerance to valve endothelial cells through gene transfer.
    Li Y; McCormack AM; Brand NJ; Yacoub MH
    J Heart Valve Dis; 2000 May; 9(3):439-44. PubMed ID: 10888103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro prevention of cell-mediated xeno-graft rejection via the Fas/FasL-pathway in CrmA-transducted porcine kidney cells.
    Fujino M; Li XK; Suda T; Hashimoto M; Okabe K; Yaginuma H; Mikoshiba K; Guo L; Okuyama T; Enosawa S; Amemiya H; Amano T; Suzuki S
    Xenotransplantation; 2001 May; 8(2):115-24. PubMed ID: 11328582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [FasL-Fas/APO-1 (CD95) system].
    Sun CK; Ju G
    Sheng Li Ke Xue Jin Zhan; 1997 Apr; 28(2):136-8. PubMed ID: 11038707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.